BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37551909)

  • 1. The Devil Is in the Details.
    Piek JM; Tamussino K
    J Am Coll Surg; 2023 Nov; 237(5):796-797. PubMed ID: 37551909
    [No Abstract]   [Full Text] [Related]  

  • 2. The devil is in the details: Transposable element analysis of the Tasmanian devil genome.
    Nilsson MA
    Mob Genet Elements; 2016; 6(1):e1119926. PubMed ID: 27066301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth, productivity, and relative extinction risk of a data-sparse devil ray.
    Pardo SA; Kindsvater HK; Cuevas-Zimbrón E; Sosa-Nishizaki O; Pérez-Jiménez JC; Dulvy NK
    Sci Rep; 2016 Sep; 6():33745. PubMed ID: 27658342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of major histocompatibility complex class I and class II genes from the Tasmanian devil (Sarcophilus harrisii).
    Siddle HV; Sanderson C; Belov K
    Immunogenetics; 2007 Sep; 59(9):753-60. PubMed ID: 17673996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A human adenovirus encoding IFN-γ can transduce Tasmanian devil facial tumour cells and upregulate MHC-I.
    Kayigwe AN; M Darby J; Lyons AB; L Patchett A; Lisowski L; Liu GS; S Flies A
    J Gen Virol; 2022 Nov; 103(11):. PubMed ID: 36382885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Devil Is in the Details but the Details Are Not in NHAMCS.
    Connors NJ; Nelson LS
    J Med Toxicol; 2016 Jun; 12(2):145-7. PubMed ID: 27083902
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification and analysis of divergent immune gene families within the Tasmanian devil genome.
    Morris KM; Cheng Y; Warren W; Papenfuss AT; Belov K
    BMC Genomics; 2015 Nov; 16():1017. PubMed ID: 26611146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [[The Devil in the Details: Women's Right to Abortion and Health Organization].].
    Pioggia A
    Med Secoli; 2016; 28(1):149-172. PubMed ID: 28854328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Devil Facial Tumours: Towards a Vaccine.
    Owen RS; Siddle HV
    Immunol Invest; 2019 Oct; 48(7):719-736. PubMed ID: 31161832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interobserver reproducibility of the diagnosis of differentiated exophytic vulvar intraepithelial lesion (DEVIL) and the distinction from its mimics.
    Neville G; Chapel DB; Crum CP; Song SJ; Yoon JY; Lee KR; Kolin DL; Hirsch MS; Nucci MR; Parra-Herran C
    Histopathology; 2021 Dec; 79(6):957-965. PubMed ID: 34214216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiated exophytic vulvar intraepithelial lesion: Clinicopathologic and molecular analysis documenting its relationship with verrucous carcinoma of the vulva.
    Akbari A; Pinto A; Amemiya Y; Seth A; Mirkovic J; Parra-Herran C
    Mod Pathol; 2020 Oct; 33(10):2011-2018. PubMed ID: 32427961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells from the Tasmanian Devil (
    Weeratunga P; Shahsavari A; Fennis E; Wolvetang EJ; Ovchinnikov DA; Whitworth DJ
    Stem Cells Dev; 2020 Jan; 29(1):25-37. PubMed ID: 31709909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Density trends and demographic signals uncover the long-term impact of transmissible cancer in Tasmanian devils.
    Lazenby BT; Tobler MW; Brown WE; Hawkins CE; Hocking GJ; Hume F; Huxtable S; Iles P; Jones ME; Lawrence C; Thalmann S; Wise P; Williams H; Fox S; Pemberton D
    J Appl Ecol; 2018 May; 55(3):1368-1379. PubMed ID: 30089931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dental Pulp Stem Cells - Exploration in a Novel Animal Model: the Tasmanian Devil (Sarcophilus harrisii).
    Graham CM; Kremer KL; Koblar SA; Hamilton-Bruce MA; Pyecroft SB
    Stem Cell Rev Rep; 2018 Aug; 14(4):500-509. PubMed ID: 29737458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease.
    Tovar C; Patchett AL; Kim V; Wilson R; Darby J; Lyons AB; Woods GM
    PLoS One; 2018; 13(4):e0196469. PubMed ID: 29702669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of Cryptosporidium and Giardia from the Tasmanian devil (Sarcophilus harrisii).
    Wait LF; Fox S; Peck S; Power ML
    PLoS One; 2017; 12(4):e0174994. PubMed ID: 28423030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sympathy for the devil: a conservation strategy for devil and manta rays.
    Lawson JM; Fordham SV; O'Malley MP; Davidson LN; Walls RH; Heupel MR; Stevens G; Fernando D; Budziak A; Simpfendorfer CA; Ender I; Francis MP; Notarbartolo di Sciara G; Dulvy NK
    PeerJ; 2017; 5():e3027. PubMed ID: 28316882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogen-activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cells.
    Brown GK; Tovar C; Cooray AA; Kreiss A; Darby J; Murphy JM; Corcoran LM; Bettiol SS; Lyons AB; Woods GM
    Immunol Cell Biol; 2016 Aug; 94(7):673-9. PubMed ID: 27089941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex determination by SRY PCR and sequencing of Tasmanian devil facial tumour cell lines reveals non-allograft transmission.
    Cui X; Wang Y; Hua B; Miller W; Zhao Y; Cui H; Kong X
    Biochem Biophys Res Commun; 2016 May; 474(1):29-34. PubMed ID: 27084454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Devil We Don't Know: Investigating Habitat and Abundance of Endangered Giant Devil Rays in the North-Western Mediterranean Sea.
    Notarbartolo di Sciara G; Lauriano G; Pierantonio N; Cañadas A; Donovan G; Panigada S
    PLoS One; 2015; 10(11):e0141189. PubMed ID: 26580814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.